Growth Metrics

Merck (MRK) Cash from Investing Activities (2016 - 2026)

Merck has reported Cash from Investing Activities over the past 18 years, most recently at -$10.2 billion for Q1 2026.

  • Quarterly Cash from Investing Activities fell 586.62% to -$10.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$22.5 billion through Mar 2026, down 186.35% year-over-year, with the annual reading at -$13.7 billion for FY2025, 77.67% down from the prior year.
  • Cash from Investing Activities was -$10.2 billion for Q1 2026 at Merck, up from -$11.2 billion in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $53.0 million in Q4 2023 and troughed at -$11.4 billion in Q2 2023.
  • The 5-year median for Cash from Investing Activities is -$1.4 billion (2024), against an average of -$3.0 billion.
  • Year-over-year, Cash from Investing Activities soared 103.03% in 2023 and then crashed 2824.53% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.7 billion in 2022, then surged by 103.03% to $53.0 million in 2023, then crashed by 2824.53% to -$1.4 billion in 2024, then tumbled by 675.69% to -$11.2 billion in 2025, then grew by 8.85% to -$10.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Cash from Investing Activities are -$10.2 billion (Q1 2026), -$11.2 billion (Q4 2025), and -$283.0 million (Q3 2025).